Table 5 Acceptance of ACT and discounts (N = 164, excl. orphan drugs)
From: Benefit assessment in Germany: implications for price discounts
Acceptance of ACT set by GBA: no | ||||||||||
Additional benefit category | ACT ≤ 1 | ACT > 1 | ||||||||
n | Mean | Min | Max | SD | n | Mean | Min | Max | SD | |
Overall | 37 | 20.25 | 3.40 | 67.30 | 13.21 | 30 | 22.46 | 0.00 | 53.71 | 11.88 |
Overall with additional benefit | 18 | 16.63 | 4.74 | 39.65 | 10.05 | 9 | 19.72 | 0.00 | 51.67 | 15.30 |
Considerable | 7 | 18.05 | 10.07 | 32.87 | 7.93 | 4 | 15.06 | 10.07 | 23.15 | 6.29 |
Minor | 8 | 16.70 | 4.74 | 39.65 | 13.26 | 5 | 23.45 | 0.00 | 51.67 | 19.99 |
Non-quantifiable | 3 | 13.16 | 10.07 | 19.35 | 5.36 | 0 | – | – | – | – |
No | 19 | 20.25 | 3.40 | 67.30 | 13.21 | 21 | 23.63 | 3.16 | 53.71 | 10.30 |
Acceptance of ACT set by GBA: yes | ||||||||||
Additional benefit category | ACT ≤ 1 | ACT > 1 | ||||||||
n | Mean | Min | Max | SD | n | Mean | Min | Max | SD | |
Overall | 44 | 24.14 | 0.00 | 78.02 | 15.22 | 53 | 23.07 | 2.01 | 58.73 | 14.25 |
Overall with additional benefit | 17 | 23.26 | 6.35 | 35.19 | 12.60 | 27 | 22.05 | 2.01 | 58.73 | 14.69 |
Major | 1 | 13.64 | 13.64 | 13.64 | – | 0 | – | – | – | – |
Considerable | 7 | 19.05 | 6.35 | 35.19 | 11.70 | 8 | 29.08 | 10.38 | 42.54 | 14.21 |
Minor | 7 | 31.58 | 19.80 | 46.44 | 11.77 | 15 | 18.78 | 2.01 | 58.73 | 16.10 |
Non-quantifiable | 2 | 13.64 | 13.64 | 13.64 | 0.00 | 4 | 20.25 | 19.25 | 21.25 | 1.15 |
No | 27 | 24.69 | 0.00 | 78.02 | 16.86 | 25 | 24.73 | 2.01 | 49.52 | 13.92 |
Additional harm potential | 0 | – | – | – | – | 1 | 9.00 | 9.00 | 9.00 | – |